Subsequent validation confirmed that MYC overexpression in two highly chemo‐sensitive SCLC PDX models induced complete chemoresistance, emphasizing the significant impact of these oncogenes on chemoresistance development in SCLC. The gene discussed is MYC; the disease is small cell lung carcinoma.